Abstract: We present a new method for the synthesis of bis-triazolones 3, which result from the processing of novel bis-amidrazones 2 with ethyl chloroformate. The bis-amidrazones 2 are prepared by the reaction of the C NMR studies as well as elemental analysis. The molecular structure of the compound 3c was also determined via an X-ray analysis. The antimicrobial activity of the synthesized compounds was evaluated against a panel of 09 bacterial strains using broth microdilution methods. Results showed that compounds exhibited moderate to strong antibacterial activity against the tested species.
Introduction
Much attention has been devoted to the synthesis of bisheterocyclic compounds, which exhibit strong biological activities, including anticancer, antibacterial, anti-tumor, and antimycobacterial activities [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Among such compounds are the bistriazoles derivatives, which also possess significant biological activities [11] [12] [13] [14] [15] . In this paper, we propose the synthesis and in vitro antibacterial activity evaluation of a series of novel bis-amidrazones 2 and bistriazolones 3. The Bis-triazolones 3 were prepared from a novel series of bis-amidrazones 2, the latter being synthesized from N 1 -tosylhydrazonates 1.
Results and Discussion
The required N 1 -tosylhydrazonates 1 were prepared as described in the literature 16 . The N 1 -tosylhydrazonates 1 have electrophilic centers and they are very reactive toward reactants having NH 2 -moiety such as amines, hydrazide, etc [16] [17] . In fact, refluxing in ethanol of two moles of N 1 -tosylhydrazonates 1 with one mole of diamine derivatives yields bis-(1-tosylamidrazone) alkanes 2 (Scheme 1). Such a reaction consists of a double nucleophilic attack by the two nitrogen atoms of diamine on the electrophilic center of two moles of N 1 -tosylhydrazonate derivatives. The structural assignments of the new compounds were based on their elemental analysis and spectral (IR, 1 H NMR and 13 C NMR) data. The characterisation data of all the new compounds is presented in experimental section.
During the spectroscopic characterisation of bis-amidrazones 2, we noted the doubling of each of the 1 H-NMR and 13 C-NMR signals, which implies the existence of two isomers in solution (DMSO-d 6 ), as shown in Scheme 2.
Scheme 2. Isomeric forms
IR spectra of compounds 2 shows absorption bands in the range of 1645-1655 cm -1 , which are attributed to the C=N group, whereas amino stretching vibration bands appear in the range of 3100 -3255 cm -1 . The NMR spectrum of 2 shows essentially the absence of the signal of ethoxy group of the parent N 1 -tosylhydrazonates 1, and it shows the presence of the characteristic resonance signals of protons introduced by the diamine derivatives. The 1 H NMR spectrum reveals a singlet in the range of 6.33-6.81 ppm and broad peaks in the range of 8.52-8.75 ppm which are due to the NH protons. The 13 C NMR signals for the two -C==N-groups were recorded at about 159 and 164 ppm.
Reaction of bis-amidrazones 2, in cold conditions, with two molar equivalents of ethyl choloroformate in anhydrous ethanol in the presence of two molar equivalents of pyridine, yields the desired bis-triazolones 3 (Scheme3). 
Scheme 3. Synthetic pathway of bis-triazolones 3
The reaction involves a double nucleophilic attack of the nitrogen of the two amidrazones moiety on the carbonyl center of the chloroformate.
The assignment of selected characteristic IR bands provides significant indications for the formation of bis-triazolone 3. No absorption was observed in the 3100-3250 cm -1 range, providing evidence for absence of the amino group. The appearance of an intense band at around 1735 cm -1 shows a (C=O) stretch of triazolone, and the absorption band in the range of 1590-1610 cm -1 can be attributed to the vibration of the -C=N group. The structure of the compounds 3 is confirmed by 1 H and 13 C NMR. The NMR spectra shows clearly the symmetry that is present in these compounds. In the 1 H NMR spectra of bistriazolone 3, we note in particular the absence, in the ranges of 6.33-6.81 ppm and 8.52-8.75 ppm, of the characteristic signals of the NH groups, which existed in the parent bisamidrazones 2. The 13 C-NMR signal for the C=O group was observed at around 151 ppm, whereas the signal for the C=N group was observed at values in the range of 147-150 ppm.
The formation of bis-triazolones 3 was further confirmed by X-ray diffraction. The crystal data and parameters relevant to the structure determination and refinement for the bistriazolone 3c are listed in Table 1 . The crystals 3c were obtained by slow evaporation of an ethanol solution; a white block shaped crystal of this compound with approximate dimensions of 0.56 x 0.1 x 0.1 was mounted on a Bruker Smart diffractometer equipped with an Apex CCD area detector. Intensity data were collected using a graphite monochromated Mok α radiation (λ = 0.71073 Å) at 293 K.
The structure was solved by direct Methods (SHELXS 79) 18 and refined by full matrix least squares on . The X-ray crystallographic analysis of the 1,8-bis-(5-methyl-2-tosyl-1,2,4-triazol-3-one-4-yl)octane 3c revealed that the molecule is centrosymetric. In the crystal structure, the rings are coplanar, in the title compound, the first ring built up by the atoms (C3, C4, C5, C6, C7, C8) is planar (rms deviation of fitted atoms equal to 0.002). The second ring built up by the atoms (N1, N3, C2, N2, C1,) is less planar (rms deviation of fitted atoms equal to 0.0128), but the plane of the triazolone ring forms greater angles to the molecular plane (N2-C9-C10 angle is 112°). 
112.7(3) C7-C6-C13 121.0(4) C1-N1-S1 124.0(2) N3-C2-C14 123.4(4) C8-C7-C6 121.4(4) N3-N1-S1 120.7(2) N2-C2-C14 123.9(4) C7-C8-C3 119.7(4) C2-N2-C1 108. 
Antibacterial activity
All new compounds were evaluated for their in vitro antibacterial activities against human pathogens.
In the present study, we have tested the antibacterial activities against a panel of human pathogenic microorganisms representing different species of different ecosystems and known as opportunists for man and animals and causes food contamination. The in vitro antibacterial activities against Gram positive and negative bacteria were determined using broth microdilution method.
As shown in Table 3 , all the new compounds possessed moderate antibacterial activities against both Gram-positive and Gram-negative bacteria. The activity of the new compounds depends on their concentration and the tested bacteria.
The MICs values were found for 2a-g and 3a-g, ranging from 0.46 to 4.72 mM. A comparative study of the MICs values indicates that the compound 2a and 2f are more active than the other bis-(1-tosylamidrazone)alkanes. The compounds 2a and 2f exhibited antibacterial activities with MICs values of 0.5 and 1.16 mM respectively, while the antibacterial activities of the others compounds were observed in 2.11 and 4.72 mM. Compound 3g showed a high bactericidal activity against Gram positive bacteria (MICs: 0.46 and 0.92 mM) compared to the others bis-triazolones (MICs: 2.02 and 4.04 mM).
When examining the effectiveness of the compounds against the Gram positive and negative bacteria, we observed that the Gram positive are more susceptible to the synthesized compounds than Gram negative ones. This effect could be attributed in part to the great complexity of the double membrane-containing cell envelope in Gram negative bacteria compared to the single membrane structure of positive ones 20 . In the current study, the growth of Enterococcus faecalis was remarkably inhibited by the synthesized bis-triazolones and bis-(1-tosylamidrazone)alkanes derivatives. These results showed that the synthesized compounds could be used to minimize problems of drug resistance and protect foods against microbial enterotoxins that cause gastroenteritis 21 . From our observations, we thought that increasing (CH 2 ) n unit into the ligand might provide interesting biological properties, like those of 3g in bis-triazolones compounds. The R substitution by CH 3 or Et seemed to be a secondary parameters for antibacterial activity of bis-triazolones and bis-(1-tosylamidrazone)alkanes compounds. 
Conclusion
This study reports the successful synthesis and characterization of new bis(1-tosylamidrazone-4-yl) alkane derivatives 2a-g and bis(5-alkyl-2-tosyl-1,2,4-triazol-3-one-4-yl) alkane derivatives 3a-g. The synthesized compounds were tested for their antibacterial activity. Results showed that the tested compounds exhibited moderate to strong antibacterial activity.
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Experimental Section
Melting points were determined on Electrothermal 9100 apparatus and are uncorrected. IR Spectra were determined from KBr pellets on a JASCO FT-IR-420 spectrometer whose precision is of 2 cm -1 covering field 400 -4000 cm -1 . The NMR spectra were recorded in CDCl 3 or in DMSO-d 6 on a Bruker Avance spectrometer (300 MHz for 1 H, 75 MHz for 13 C). 1 H and 13 C chemical shifts are given on the δ scale (ppm) and are referenced to internal TMS. The multiplicities of the signals are indicated by the following abbreviations: s: singlet, d: doublet, t: triplet, q: quadruplet, m: multiplet, br: broad. Elemental analyses were performed at the Service de Microanalyse, Nancy. The reactions and the purity of substances were monitored by thin layer chromatography (TLC) (elution systems chloroform-ethanol, 9:1) using aluminium sheets with silica gel 60 F 254 Merck. All reactions, unless otherwise stated, were carried out under nitrogen atmosphere in dry solvents under anhydrous conditions. N 1 -tosylhydrazonates 1 were synthesized according to the literature procedures 16 . All other reagents were purchased and used without purification. Single crystal X-ray diffraction studies were realized on a KPPACCD diffractometer. Solution and refinement: direct methods SHELXS-79 18 for structure solution and SHELXL-97 19 software package for refinement and data output.
General procedure for the synthesis of bis-(1-tosylamidrazone-4-yl)alkanes (2)
A mixture of N 1 -tosylhydrazonate 1 (0,002 mol), diamino-alkane (0,001mol) and 30 mL of anhydrous ethanol was refluxed. After reaction completion (4-8 h), as indicated by TLC, the solvent was removed by evaporation and the precipitated product 2 obtained by addition of diethyl ether, was re-crystallised from methanol. -(5-alkyl-2-tosyl-1,2,4-triazol-3-one-4-yl) 
1,6-bis(1-tosylacetamidrazone-4-yl)hexane (2a):

General procedure of the synthesis of bis
alkane (3)
To a solution of 0,001 mole of bis-amidrazone 2 and 0,002 mole of pyridine with 20 mL of anhydrous ethanol, stirred magnetically in ice-cold water, was added dropwise a solution of 0,002 mole of ethyl chloroformate within 10 mL of anhydrous ethanol. Once the mixing is completed, the mixture was stirred during 24 hours (TLC monitoring, SiO 2 , chloroform/ethanol (9/1)). After evaporation of the solvent, 30 ml of chloroform was added and the mixture was washed three times with 20 mL of distillated water. The chloroform layer separated, dried and the solvent was evaporated to give the resulting compound 3 precipitated soon by the addition of diethyl ether. The resulting compounds were re-crystallized from ethanol. -2-tosyl-1,2,4-triazol-3-one-4-yl) 10-bis (5-ethyl-2-tosyl-1,2,4-triazol-3-one-4-yl) CFU/ml bacteria were used. DMSO was used as negative control.
1,8-bis (5-methyl
Antibacterial activity
Microorganisms and growth conditions
Minimum inhibitory concentration measurement
Minimum inhibitory concentrations (MIC) of the synthesized compounds were determined according to Gulluce et al 22 with minor modifications against a panel of 08 microorganisms representing different species of different ecosystems. The test was performed in sterile 96-well microplates with a final volume in each microplate well of 100 µL. For susceptibility testing, 100 μL of Mueller-Hinton broth was distributed from the second to the twelfth test wells. A stock solution of the synthesized compounds was prepared by dissolving 100 µL of the tested compounds in dimethyl sulfoxide and then adjusted to a final concentration of 50 mg/mL by Mueller-Hinton broth. The first well of the microplate was prepared by dispensing 160 µL of the growth medium and 40 µL of the synthesized compounds to reach a final concentration of 10 mg/mL and then 100 μL of scalar dilutions were transferred from the second to the ninth well. Thereafter and from each well, 10 μL of the suspension were removed and replaced by the bacterial suspensions to final inoculum concentrations of 10 6 CFU/ml for bacteria. The final concentrations of the synthesized compounds adopted to evaluate the antimicrobial activity were 0.039 to 10 mg/mL. The 10th well was considered as positive growth control containing Mueller-Hinton media for bacterial strains, since no of the synthesized compounds was added. The plates were then covered with the sterile plate covers and incubated at 37 °C for 24 h for bacterial strains. The MIC was defined as the lowest concentration of the total essential oil at which the microorganism does not demonstrate visible growth after incubation. As an indicator of microorganism growth, 25 µL of piodonitrotetrazolium violet (INT) (0.5 mg/mL) dissolved in sterile water were added to the wells and incubated at 37 °C for 30 min. Where microbial growth was inhibited, the solution in the well remained clear after incubation with INT. All experiments were performed in triplicate.
